ecns [expanded by feedex.net]
ecns
Five Chinese pharmaceutical enterprises fined
http://www.ecns.cn/2016/01-28/197492.shtml
Jan 28th 2016, 16:55
Thursday Jan 28, 2016
China's Bureau of Price Supervision and Anti-Monopoly has punished five domestic pharmaceutical enterprises on price monopoly agreement.
This is the first anti-monopoly case after the country opened up national drug pricing. Five companies, including two from the municipalities of Chongqing and Shanghai -- have been ordered to pay fines of five to eight percent of total sales in 2014. Altogether, that's nearly 4 million yuan or 550 thousand US dollars.
"This is the first case of monopoly agreement we have investigated in the medicine sector. The value of this case itself is not significant, but it's typical. Not only was it horizontal, but there was action in collusion with the negotiation pricing problem, as well as division sales area, and the issue of market division," said Lu Yanchun, deputy director of Anti-Monopoly Bureau, NDRC.
¡¡¡¡
Guangzhou offers special policies to attract foreign pharma firmsGains for infrastructure stocks countered by declines for financial, pharma firmsPharma firms mull more Chinese
Gov't sets eliminating outdated capacity 'a priority'China, U.S. should jointly promote solutions to more global issues: XiChina to carry out agriculture reforms to boost growthCampaign sees 857 fugitives returned to ChinaSupport lacking for car ban plan in Beijing
Human Go players face challenges from AI China boasts world's second largest number of think tanks 73 bodies recovered from rubble of Shenzhen landslide ROK returning more remains of Chinese killed in Korean War Beijing plans for 10 more bonded stores
You are receiving this email because you subscribed to this feed at https://blogtrottr.com
If you no longer wish to receive these emails, you can unsubscribe here:
https://blogtrottr.com/unsubscribe/qhG/Zc7fXt
No comments:
Post a Comment